https://www.selleckchem.com/pr....oducts/Staurosporine
Treatment prevalence was lower for those who had higher family income and education, were not employed full time, were married, were younger than age 26 years or older than age 50 years, and were Asian. Even though the treatment gap is reduced among those with multiple SUDs, it remains large. The most common and undertreated comorbid SUD combinations, in conjunction with the most underserved groups, could be targeted to facilitate treatment uptake. Even though the treatment gap is reduced among those with multiple SUDs, it remains
Like
Comment
Share
